Insights on health, access and innovation

Oncology continues to push the boundaries – of both science and HTA

This year’s #ESMO2026 (23-27 Oct) will once again showcase the cutting edge of medical science – bringing excitement for life science enthusiasts and more importantly, hope to increasing numbers of patients

Part 2: Asset level commercial strategies alongside national level system change

Innovative commercial strategies to achieve an optimal net price have never been more critical – and achieving them will demand a higher appetite for risk from all parties.

Part 1: How to influence national systems to help mitigate MFN headwinds

The UK example demonstrate that national system reform is achievable. But it requires the use of a new playbook.

NHS pharmaceuticals negotiator to join Newmarket Strategy

Health and life sciences consultancy, Newmarket Strategy, has added another NHS and government leader to its top team. Robert Kettell, currently the NHS’s Director of Medicines Negotiation, will join Newmarket as…

Newmarket Strategy acquires Visible Analytics to complete its full-service market access offer

Newmarket Strategy, a specialist healthcare and life sciences consultancy, announces today the successful acquisition of Visible Analytics, experts in Health Economics and Outcomes Research (HEOR) and data analytics.

The Future of Healthcare and Life Sciences Research Conference 2025

The Future of Life Sciences event brought together leaders from across the NHS, government, academia, and industry to tackle one of the UK’s greatest opportunities—and challenges: unlocking the full potential of…